Glenmede Trust’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-170
Closed -$8K 1520
2020
Q3
$8K Hold
170
﹤0.01% 1947
2020
Q2
$8K Sell
170
-5
-3% -$270 ﹤0.01% 1944
2020
Q1
$9K Hold
175
﹤0.01% 2457
2019
Q4
$9K Hold
175
﹤0.01% 2457
2019
Q3
$8K Buy
175
+33
+23% +$1.66K ﹤0.01% 2443
2019
Q2
$7K Buy
142
+38
+37% +$1.84K ﹤0.01% 2510
2019
Q1
$4K Hold
104
﹤0.01% 2665
2018
Q4
$5K Buy
+104
New +$5.92K ﹤0.01% 2530
2018
Q2
Sell
-104
Closed -$4K 2024
2018
Q1
$4K Hold
104
﹤0.01% 2448
2017
Q4
$4K Hold
104
﹤0.01% 2448
2017
Q3
$3K Hold
104
﹤0.01% 2473
2017
Q2
$3K Hold
104
﹤0.01% 2394
2017
Q1
$3K Buy
+104
New +$3.42K ﹤0.01% 2394
2016
Q4
Sell
-8,517
Closed -$273K 2505
2016
Q3
$273K Sell
8,517
-1,186
-12% -$38.4K ﹤0.01% 1108
2016
Q2
$298K Sell
9,703
-3,660
-27% -$114K ﹤0.01% 1070
2016
Q1
$398K Sell
13,363
-593
-4% -$16.4K ﹤0.01% 981
2015
Q4
$384K Buy
13,956
+1,655
+13% +$47.1K ﹤0.01% 1011
2015
Q3
$375K Buy
+12,301
New +$428K ﹤0.01% 1012

Other funds holding EHC

Glenmede Trust's EHC Position: Q4 2020 in Review

Glenmede Trust sold out of Encompass Health (EHC) in Q4 2020, closing a stake of 170 shares — an estimated $8K sold.

Glenmede Trust first reported a position in EHC in Q3 2015 and held it in 18 quarters. The position peaked at $398K in Q1 2016. 405 funds tracked by Wall St. Rank hold EHC as of Q4 2020.

  • Glenmede Trust reported no remaining Encompass Health position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 170 Encompass Health shares in Q4 2020, an estimated $8K.
  • Glenmede Trust first reported a position in Encompass Health in Q3 2015 and held it in 18 quarters.
  • Glenmede Trust's Encompass Health position peaked at $398K in Q1 2016.
  • 405 funds tracked by Wall St. Rank held Encompass Health as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.